Platelet dysfunction caused by differentially expressed genes as key pathogenic mechanisms in COVID-19

Area of Science:

• Hematology
• Virology
• Molecular Biology

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, presents a significant global health challenge.
• Patients with COVID-19 frequently exhibit hematological abnormalities, particularly platelet dysfunction, which correlates with disease severity and mortality.
• SARS-CoV-2 infection alters platelet gene expression and function, with evidence suggesting platelets may internalize viral mRNA independently of ACE2.

Purpose of the Study:

• To review the relationship between COVID-19, platelets, and SARS-CoV-2-induced circulatory damage.
• To analyze differentially expressed mRNA in platelets post-SARS-CoV-2 infection and identify key genes.
• To explore the impact of SARS-CoV-2 on platelet transcriptomic abnormalities and dysfunction, and discuss treatment strategies for related complications.

Main Methods:

• Literature review on COVID-19, platelet function, and circulatory system damage.
• Bioinformatic analysis of differentially expressed mRNA in platelets following SARS-CoV-2 infection.
• Identification of eight hub genes (NLRP3, MT-CO1, CD86, ICAM1, MT-CYB, CASP8, CXCL8, CXCR4).
• Exploration of SARS-CoV-2 effects on platelet transcriptomics and function based on identified hub genes.

Main Results:

• Significant changes in platelet gene expression profiles were confirmed in SARS-CoV-2 infected individuals.
• Eight hub genes were identified as critical in mediating the effects of SARS-CoV-2 on platelets.
• SARS-CoV-2 infection leads to platelet transcript abnormalities and dysfunction, linked to disease severity.

Conclusions:

• Platelet dysfunction is a critical factor in COVID-19 pathogenesis and patient outcomes.
• Understanding the identified hub genes provides insights into SARS-CoV-2-induced platelet abnormalities.
• Management strategies for platelet dysfunction complications are crucial for COVID-19 patient care and recovery.